肥厚型心肌病中心脏能量代谢改变与线粒体功能障碍
该研究对27例肥厚型心肌病(HCM)患者和13例正常供体心脏的心肌样本进行多组学分析,发现HCM心脏存在脂肪酸代谢失调、高能磷酸盐代谢物减少、线粒体结构损伤和氧化呼吸降低,且线粒体自噬清除未上调。结果表明代谢信号紊乱和线粒体功能障碍是HCM的共同致病机制,提示改善代谢功能可能成为治疗靶点。
要点
- HCM心脏显示脂肪酸代谢紊乱及高能磷酸盐(ATP、ADP、磷酸肌酸)减少。
- HCM心肌线粒体严重损伤比例增加,嵴密度降低,氧化呼吸和柠檬酸合酶活性下降。
- 尽管线粒体损伤显著,HCM心脏未能上调线粒体自噬清除。
核心结论
- 代谢信号紊乱和线粒体功能障碍是HCM患者的共同致病机制。
研究设计与样本
- 研究纳入27例HCM患者和13例正常对照(供体心脏)的心肌样本,进行多组学(转录本、代谢物、复杂脂质)、超微结构和功能分析。
主要发现
- 整合组学分析显示脂肪酸代谢显著失调,酰基肉碱减少,游离脂肪酸积累。
- HCM心脏高能磷酸盐代谢物(ATP、ADP、磷酸肌酸)减少,参与肌酸激酶和ATP合成的线粒体基因表达降低。
- 电镜显示严重损伤线粒体比例增加、嵴密度降低,伴随柠檬酸合酶活性和线粒体氧化呼吸降低。
- 线粒体异常与活性氧升高和抗氧化防御降低相关。
- 尽管线粒体损伤显著,HCM心脏未能上调线粒体自噬清除。
临床怎么用
- 改善代谢功能和减少线粒体损伤可能成为 attenuating HCM 临床疾病的新治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a complex disease partly explained by the effects of individual gene variants on sarcomeric protein biomechanics. At the cellular level, HCM mutations most commonly enhance force production, leading to higher energy demands. Despite significant advances in elucidating sarcomeric structure-function relationships, there is still much to be learned about the mechanisms that link altered cardiac energetics to HCM phenotypes. In this work, we test the hypothesis that changes in cardiac energetics represent a common pathophysiologic pathway in HCM. METHODS: We performed a comprehensive multiomics profile of the molecular (transcripts, metabolites, and complex lipids), ultrastructural, and functional components of HCM energetics using myocardial samples from 27 HCM patients and 13 normal controls (donor hearts). RESULTS: Integrated omics analysis revealed alterations in a wide array of biochemical pathways with major dysregulation in fatty acid metabolism, reduction of acylcarnitines, and accumulation of free fatty acids. HCM hearts showed evidence of global energetic decompensation manifested by a decrease in high energy phosphate metabolites (ATP, ADP, and phosphocreatine) and a reduction in mitochondrial genes involved in creatine kinase and ATP synthesis. Accompanying these metabolic derangements, electron microscopy showed an increased fraction of severely damaged mitochondria with reduced cristae density, coinciding with reduced citrate synthase activity and mitochondrial oxidative respiration. These mitochondrial abnormalities were associated with elevated reactive oxygen species and reduced antioxidant defenses. However, despite significant mitochondrial injury, HCM hearts failed to upregulate mitophagic clearance. CONCLUSIONS: Overall, our findings suggest that perturbed metabolic signaling and mitochondrial dysfunction are common pathogenic mechanisms in patients with HCM. These results highlight potential new drug targets for attenuation of the clinical disease through improving metabolic function and reducing mitochondrial injury.
引用
- Ranjbarvaziri S, Kooiker KB, Ellenberger M, et al. Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy. Circulation. 2021. PMID: 34672721. doi:10.1161/CIRCULATIONAHA.121.053575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。